HIV Prevention Program for Older Black Women
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a group-based program can enhance HIV knowledge, prevention behaviors, and testing among older Black women living in subsidized housing. Participants will either begin the program immediately (Adapted W2W) or after a short wait, engaging in discussions and activities over several weeks. The trial seeks to assess whether this tailored approach is effective and engaging for the women involved. Women who are 50 or older, live in certain areas, and identify as Black or African American may be suitable candidates. As an unphased trial, this study provides participants the opportunity to contribute to research that could lead to more effective community health programs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on group discussions and education rather than medication changes.
What prior data suggests that this HIV prevention program is safe for older Black women?
Research shows that participants generally like the Adapted Woman-2-Woman (W2W) program. In earlier studies, women who joined similar programs reported satisfaction and regular attendance, indicating the program is engaging and manageable. These studies have not reported major negative effects or adverse reactions.
This trial involves a behavioral program focused on teaching and skills rather than medicine, typically resulting in fewer safety concerns compared to trials with new drugs. Overall, previous research suggests the Adapted W2W program is safe and easy to handle.12345Why are researchers excited about this trial?
Researchers are excited about the Adapted W2W program because it specifically targets older Black women, a group often overlooked in HIV prevention efforts. Unlike standard prevention methods that might not consider age-related factors, this program includes educational sessions that address aging-related HIV knowledge and prevention practices. By focusing on these tailored interventions, the program aims to reduce HIV transmission within this demographic, offering a culturally and age-sensitive approach that current treatments may lack.
What evidence suggests that this HIV prevention program is effective for older Black women?
Research shows that the "Woman-2-Woman" (W2W) program, which participants in this trial may receive, is a promising new version of an HIV prevention program for older Black women. This program specifically addresses their unique experiences and needs. Studies have found that similar programs can increase knowledge about HIV and improve prevention behaviors. Participants in earlier versions of the program reported high satisfaction and greater awareness of HIV risks and prevention methods. This suggests that the updated W2W program could encourage older Black women to use condoms more frequently and get tested for HIV. Overall, the evidence supports the potential success of this customized approach.16789
Who Is on the Research Team?
Laneshia Conner, PhD
Principal Investigator
University of Kentucky
Are You a Good Fit for This Trial?
This trial is for older Black women aged 50 and above living in subsidized housing. It's designed to see if a group-based HIV prevention program can help them learn more about HIV, use condoms, and get tested. Participants should be willing to share their reproductive health history and sexual health decisions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants take part in a group-based HIV prevention program with four weekly sessions including group discussions, education, and skill-building activities
Follow-up
Participants complete questionnaires to assess HIV knowledge, condom use, and testing behavior
Open-label extension (optional)
Participants in the waitlist control group receive the intervention 8 weeks after the initial group
What Are the Treatments Tested in This Trial?
Interventions
- Adapted W2W
- Waitlist Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laneshia Conner
Lead Sponsor
National Institute on Aging (NIA)
Collaborator